CONTEXT: Commercial announcement mirroring the developing trend in pulling together RWE data sources and analytical capabilities in response to the regulatory need for more granularity to assess the safety, health,
social, and economic outcomes associated with therapeutic options. This is
particularly relevant as the cannabis market scales and cannabinoid-based
therapies are adopted as mainstream therapeutic alternatives.
IMPACT: High
READ TIME: 2 min
*1. ““We are thrilled to add Helix’s unique technology and information
assets to our innovative de-identified patient health data and analytics
platform,” said Dan Barton, MOR Analytics Chief Executive Officer (CEO)
(1).” *
*2. ““We have created the nation’s only HIPAA compliant, Real World
Evidence platform integrating cannabis and de-identified healthcare data
designed to support SaaS based business performance analytics, product
safety and efficacy surveillance solutions, and evidence-based health
outcomes research .” *
*3. “With this agreement the two companies will run under a new name Forian
Inc., continuing to produce innovative healthcare information, analytics,
and technology as a new organization.” *
*4. “Both companies trust that there are momentous synergistic
opportunities to create value through combining MOR’s proprietary data and
proven experience in data architecture, technology, and analytics with
Helix’s operating software business.” *
*5. “Zachary Venegas, Executive Chairman and CEO of Helix and Scott Ogur,
Chief Financial Officer of Helix, are remaining onboard and continuing to
manage Helix alongside their MOR Analytics counterparts.” *
Source URL:
https://www.cannabissciencetech.com/view/helix-technologies-inc-and-medical-outcomes-research-analytics-llc-combine-to-form-forian-inc